Skip to main content
Clinical Trials/NCT05162599
NCT05162599CompletedNot Applicable

Evaluation of Cardiags Trimod, a New Medical Device for Screening Cardiac Abnormalities

CARDIAGS2 sites in 1 country120 target enrollmentStarted: June 8, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
CARDIAGS
Enrollment
120
Locations
2
Primary Endpoint
Heart rhythm disorders

Study Overview

Brief Summary

The current study concerns Cardiags Trimod, a new non-invasive medical device for cardiac examinations. The evaluation of its effectiveness is done relative to specific standard devices.

Detailed Description

Cardiags Trimod, the subject of this study, is a new medical device for rapid and early detection of some of cardiac abnormalities, easy to use by non-cardiologists and portable wherever the patient is. Cardiags Trimod, consisting of a device and software, allows simultaneous recording, visualization and analysis in real time of signals characteristic of cardiac function. It assists healthcare professionals by measuring characteristic time intervals of cardiac function by crossing the various signals, by detecting abnormal rhythms, and murmurs.

The study aims to assess the essential requirements : the effectiveness and safety of the device. The study is a research involving the human person.Cardiags Trimod is a medical device with low risk. There is no identified risk for the patient.The patient sample tested consists of sick and healthy individuals. The use of Cardiags Trimod is part of the patient's usual consultation. The identified Gold standards are EKG and echocardiography.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
6 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Persons suitable for receiving an echocardiogram and an electrocardiogram,
  • People who signed the consent form,

Exclusion Criteria

  • Protected and vulnerable people,
  • People refusing to participate in the study,

Outcomes

Primary Outcomes

Heart rhythm disorders

Time Frame: 15 minutes

Abnormal and irregular heart rhythm

Murmurs detection

Time Frame: 15 minutes

Evaluate the performance of Cardiags Trimod compared to a reference examination, echocardiography, for the detection of murmurs: Presence/Absence

Secondary Outcomes

  • Reproductibilty of measurements(15 minutes)
  • Security and usability(1 year)
  • Acceptability(1 year)
  • Accuracy of cardiac intervals measures(15 minutes)

Investigators

Sponsor
CARDIAGS
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials